Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma/leukemia: parallel study of 81 patients (Q42244747)
Jump to navigation
Jump to search
scientific article published on 25 February 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma/leukemia: parallel study of 81 patients |
scientific article published on 25 February 2014 |
Statements
1 reference
Dose-intensive chemotherapy including rituximab is highly effective but toxic in human immunodeficiency virus-infected patients with Burkitt lymphoma/leukemia: parallel study of 81 patients (English)
1 reference
Gerd Fätkenheuer
1 reference
Jan van Lunzen
1 reference
Dieter Hoelzer
1 reference
Blanca Xicoy
1 reference
Josep-Maria Ribera
1 reference
Markus Müller
1 reference
Olga García
1 reference
Christian Hoffmann
1 reference
Marcus Hentrich
1 reference
Carlos Grande
1 reference
Jan-Christian Wasmuth
1 reference
Jordi Esteve
1 reference
Eloy Del Potro
1 reference
Heribert Knechten
1 reference
Salut Brunet
1 reference
Christoph Mayr
1 reference
Lourdes Escoda
1 reference
Philipp Schommers
1 reference
Natalia Alonso
1 reference
Ferran Vall-Llovera
1 reference
Montserrat Pérez
1 reference
José González
1 reference
Angeles Fernández
1 reference
Jan Thoden
1 reference
Nicola Gökbuget
1 reference
Christoph Wyen
1 reference
PETHEMA Group and German HIV Lymphoma Cohort
1 reference
25 February 2014
1 reference
1 reference
55
1 reference
10
1 reference
2341-2348
1 reference
Identifiers
1 reference
1 reference